Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distention and duodenal lipid

被引:123
作者
Feinle, C
DAmato, M
Read, NW
机构
[1] NO GEN HOSP,CTR HUMAN NUTR,SHEFFIELD S5 7AU,S YORKSHIRE,ENGLAND
[2] ROTTA RES LAB SPA,MONZA,ITALY
关键词
D O I
10.1053/gast.1996.v110.pm8613041
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The combination of duodenal lipid and gastric distention induces meallike fullness followed by nausea in healthy subjects, The aim of this study was to assess the role of cholecystokinin (CCK) A receptors in these changes using the CCK-A antagonist loxiglumide, Methods: Twelve healthy subjects were studied on four occasions, during which either 0.9% saline or 20% Intralipid was infused intraduodenally on two occasions each (1 mL/min) while the proximal stomach was distended with air (100 mL/min). During each duodenal infusion, subjects received intravenous loxiglumide (10 mg . kg(-1) . h(-1)) on 1 day and placebo on the other. Intragastric pressure changes were recorded, and the subjects reported gastric sensations (fullness, nausea). Results: Loxiglumide did not influence gastric motility or sensitivity during duodenal saline infusion, Duodenal lipid reduced gastric tonic and phasic pressure activity during distentions and induced meallike fullness and nausea; sensations were reported at similar volumes but lower intragastric pressures (P < 0.001 vs. saline), Loxiglumide partially restored gastric tonic and phasic activity during lipid infusion, reduced the occurrence of meallike fullness and nausea, and increased the pressures at which sensations were reported (P < 0.001 vs. placebo), Conclusions: CCK-A receptors are involved in the induction of meallike fullness and nausea associated with intraduodenal lipid and gastric distention.
引用
收藏
页码:1379 / 1385
页数:7
相关论文
共 26 条
[1]   INTESTINAL CONTROL OF GASTRIC TONE [J].
AZPIROZ, F ;
MALAGELADA, JR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (04) :G501-G509
[2]   ANTIEMETIC PROFILE OF A NONPEPTIDE NEUROKININ-NK(1) RECEPTOR ANTAGONIST, CP-99,994, IN FERRETS [J].
BOUNTRA, C ;
BUNCE, K ;
DALE, T ;
GARDNER, C ;
JORDAN, C ;
TWISSELL, D ;
WARD, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (01) :R3-R4
[3]   CLINICAL EFFICACY AND PROKINETIC EFFECT OF THE CCK-A ANTAGONIST LOXIGLUMIDE IN NONULCER DYSPEPSIA [J].
CHUA, ASB ;
BEKKERING, M ;
ROVATI, LC ;
KEELING, PWN .
CHOLECYSTOKININ, 1994, 713 :451-453
[4]  
DEGIORGIO R, 1994, ANN NY ACAD SCI, V713, P226
[5]  
FEINLE C, 1995, GASTROENTEROLOGY S, V106, pA1025
[6]  
FEINLE C, 1995, NEUROGASTROENT MOTIL, V7, P258
[7]   PHYSIOLOGICAL-ROLE OF CHOLECYSTOKININ ON POSTPRANDIAL INSULIN-SECRETION AND GASTRIC MEAL EMPTYING IN MAN - STUDIES WITH THE CHOLECYSTOKININ RECEPTOR ANTAGONIST LOXIGLUMIDE [J].
FRIED, M ;
SCHWIZER, W ;
BEGLINGER, C ;
KELLER, U ;
JANSEN, JB ;
LAMERS, CB .
DIABETOLOGIA, 1991, 34 (10) :721-726
[8]   CHOLECYSTOKININ RECEPTORS AND VAGAL NERVES IN CONTROL OF FOOD-INTAKE IN RATS [J].
GARLICKI, J ;
KONTUREK, PK ;
MAJKA, J ;
KWIECIEN, N ;
KONTUREK, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (01) :E40-E45
[9]   ANTROPYLORODUODENAL MOTOR-RESPONSES TO INTRADUODENAL LIPID INFUSION IN HEALTHY-VOLUNTEERS [J].
HEDDLE, R ;
DENT, J ;
READ, NW ;
HOUGHTON, LA ;
TOOULI, J ;
HOROWITZ, M ;
MADDERN, GJ ;
DOWNTON, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (05) :G671-G679
[10]   INTESTINAL LIPID INHIBITS GASTRIC-EMPTYING VIA CCK AND A VAGAL CAPSAICIN-SENSITIVE AFFERENT PATHWAY IN RATS [J].
HOLZER, HH ;
TURKELSON, CM ;
SOLOMON, TE ;
RAYBOULD, HE .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1994, 267 (04) :G625-G629